Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

BACKGROUND: Alemtuzumab (MabCampath or Campath; Genzyme, Cambridge, MA) is a CD52-specific monoclonal antibody that causes profound and sustained lymphocyte depletion. Its use as an induction therapy in organ transplantation is increasing. Since our last systematic review in 2006, where we identifi...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Morgan, R, O'Callaghan, J, Knight, SR, Morris, P
Natura:	Journal article
Lingua:	English
Pubblicazione:	2012

Documenti analoghi

Systematic reviews of alemtuzumab in renal transplantation.
di: O'Callaghan, J, et al.
Pubblicazione: (2013)

Systematic reviews of alemtuzumab in renal transplantation
di: O'Callaghan, J, et al.
Pubblicazione: (2013)

Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes.
di: O'Callaghan, J, et al.
Pubblicazione: (2013)

Preservation solutions for static cold storage of kidney allografts: A systematic review and meta-analysis
di: O'Callaghan, J, et al.
Pubblicazione: (2012)

Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis.
di: O'Callaghan, J, et al.
Pubblicazione: (2012)

ALEMTUZUMAB INDUCTION IN PANCREAS TRANSPLANTATION
di: Muthusamy, A, et al.
Pubblicazione: (2011)

Systematic review of clinical practice guidelines in kidney transplantation
di: O'Donoghue, K, et al.
Pubblicazione: (2017)

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
di: Watson, C, et al.
Pubblicazione: (2005)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
di: Haynes, R, et al.
Pubblicazione: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
di: Haynes, R, et al.
Pubblicazione: (2014)

Alemtuzumab induction and steroid free immunosupprssion in pancreas transplantation.
di: Muthusamy, A, et al.
Pubblicazione: (2007)

Critical appraisal of United Kingdom clinical practice guidelines in kidney transplantation using the Appraisal of Guidelines for Research and Education (AGREE) II tool: A systematic review
di: Knight, S, et al.
Pubblicazione: (2017)

The effect of preservation solutions for storage of liver allografts on transplant outcomes: a systematic review and meta-analysis.
di: OʼCallaghan, J, et al.
Pubblicazione: (2014)

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
di: Muthusamy, A, et al.
Pubblicazione: (2008)

Steroid-free immunosuppression in pancreas transplantation using Alemtuzumab induction
di: Muthusamy, A, et al.
Pubblicazione: (2007)

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation
di: A. Benazzo, et al.
Pubblicazione: (2022-04-01)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
di: Martina Guthoff, et al.
Pubblicazione: (2020-05-01)

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
di: Flechner, S, et al.
Pubblicazione: (2005)

Terapia de indução com alentuzumabe em receptores de transplante renal Alemtuzumab induction in kidney transplant recipients
di: Edison Luiz Mandia Sampaio, et al.
Pubblicazione: (2010-03-01)

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
di: Haynes, R, et al.
Pubblicazione: (2014)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
di: Lukas K. van Vugt, et al.
Pubblicazione: (2023-11-01)

Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center
di: A Khalafi-Nezhad, et al.
Pubblicazione: (2015-10-01)

A national registry analysis of kidney allografts preserved with Marshall's Solution in the United Kingdom
di: O'Callaghan, J, et al.
Pubblicazione: (2015)

Kidney transplantation--the long term view.
di: O'Callaghan, C
Pubblicazione: (2008)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
di: Plata-Munoz, J, et al.
Pubblicazione: (2009)

Evidence based hypothermic preservation of the kidney and liver for transplantation
di: O'Callaghan, JM
Pubblicazione: (2014)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
di: Masashi Furukawa, et al.
Pubblicazione: (2022-06-01)

The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis
di: Marco Puthenparampil, et al.
Pubblicazione: (2025-01-01)

Prophylactic Peri-Nephric Drain Placement in Renal Transplant Surgery: A Systematic Review and Meta-Analysis
di: Adil S. Lakha, et al.
Pubblicazione: (2024-08-01)

Low incidence of lymphoproliferative disease post kidney transplantation with prevalent use of alemtuzumab
di: John Fredy Nieto-Ríos, et al.
Pubblicazione: (2014-01-01)

Transplant Trial Watch
di: John Matthew O’Callaghan, et al.
Pubblicazione: (2023-09-01)

Prophylactic Peri-Nephric Drain Placement in Renal Transplant Surgery: A Systematic Review and Meta-Analysis
di: Lakha, AS, et al.
Pubblicazione: (2024)

Critical appraisal of International Clinical Practice Guidelines in Kidney Transplantation using the Appraisal of Guidelines for Research and Education (AGREE) II tool: a systematic review
di: O'Donoghue, K, et al.
Pubblicazione: (2018)

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
di: Naoki Okada, et al.
Pubblicazione: (2023-08-01)

Transplant Trial Watch
di: John M. O’Callaghan, et al.
Pubblicazione: (2025-01-01)

Transplant Trial Watch
di: John M. O’Callaghan, et al.
Pubblicazione: (2024-07-01)

Transplant Trial Watch
di: John M. O’Callaghan, et al.
Pubblicazione: (2024-09-01)

Transplant Trial Watch
di: Simon R. Knight, et al.
Pubblicazione: (2024-10-01)

Transplant Trial Watch
di: Simon R. Knight, et al.
Pubblicazione: (2024-02-01)

Transplant Trial Watch
di: John M. O’Callaghan, et al.
Pubblicazione: (2024-01-01)